US 9605259
Compounds and methods for modulating protein expression
granted A61KA61K31/7115
Quick answer
US patent 9605259 (Compounds and methods for modulating protein expression) held by Ionis Pharmaceuticals, Inc. expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/7115